COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1427: Articles 14261-14270  | Next

Natural infection of SARS-CoV-2 delta variant in Asiatic lions (Panthera leo persica) in India
Mishra, A., Kumar, N., Bhatia, S., Aasdev, A., Kanniappan, S., Thayasekhar, A., Gopinadhan, A., Silambarasan, R., Sreekumar, C., Dubey, C. K., Tripathi, M., Raut, A. A., Singh, V. P.
10.1101/2021.07.02.450663 — Posted: 2021-07-02
Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals
Sapkal, G., Yadav, P. D., Sahay, R. R., Deshpande, G., Gupta, N., Nyayanit, D. A., Patil, D. Y., Kumar, S., Abraham, P., Panda, S., Bhargava, B.
10.1101/2021.07.01.450676 — Posted: 2021-07-02
A phase 1/2 randomized, double-blinded, placebo controlled ascending dose trial to assess the safety, tolerability and immunogenicity of ARCT-021 in healthy adults
Low, J. G., de Alwis, R., Chen, S., Kalimuddin, S., Leong, Y. S., Mah, T., Yuen, N., Tan, H. C., Zhang, S. L., Siim, J., Chan, Y., Syenina, A., Yee, J. X., Ong, E. Z., Sekulovich, R., Sullivan, B. B., Lindert, K., SULLIVAN, S. M., Chivukula, P., Hughes, S. G., Ooi, E. E.
10.1101/2021.07.01.21259831 — Posted: 2021-07-02
Airborne PM2.5 and the Emergence of 10 SARS-CoV-2 Variants: The Multifaceted Influence of an Airborne Pollutant on Viral Natural Selection determining SARS-CoV-2 Evolution - An Environmental Wake-up Call or an Ecological Fallacy?
Muscat Baron, Y.
10.1101/2021.06.27.21259602 — Posted: 2021-07-02
Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages
Petrone, M. E., Rothman, J. E., Breban, M. I., Ott, I. M., Russell, A., Lasek-Nesselquist, E., Kelly, K., Omerza, G., Renzette, N., Watkins, A. E., Kalinich, C. C., Alpert, T., Brito, A. F., Earnest, R., Tikhonova, I. R., Castaldi, C., Kelly, J. P., Shudt, M., Plitnick, J., Schneider, E., Murphy, S., Neal, C., Laszlo, E., Altajar, A., Pearson, C., Muyombwe, A., Downing, R., Razeq, J., Niccolai, L., Wilson, M. S., Anderson, M. L., Wang, J., Liu, C., Hui, P., Mane, S., Taylor, B. P., Hanage, W. P., Landry, M. L., Peaper, D. R., Bilguvar, K., Fauver, J. R., Vogels, C. B. F., Gardner, L. M., Pitzer, V. E., George, K. S., Adams, M. D., Grubaugh, N. D.
10.1101/2021.07.01.21259859 — Posted: 2021-07-02
The IDentif.AI 2.0 Pandemic Readiness Platform: Rapid Prioritization of Optimized COVID-19 Combination Therapy Regimens
Blasiak, A., Truong, A. T., Remus, A., Hooi, L., Seah, S. G. K., Wang, P., Chye, D. H., Lim, A. P. C., Ng, K. T., Teo, S. T., Tan, Y.-J., Allen, D. M., Chai, L. Y. A., Chng, W. J., Lye, D. C. B., Wong, J. E.-L., Chan, C. E. Z., Chow, E. K.-H., Ho, D.
10.1101/2021.06.23.21259321 — Posted: 2021-07-02
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
Larsen, S. E., Berube, B. J., Pecor, T., Cross, E., Brown, B. P., Williams, B., Johnson, E., Qu, P., Carter, L., Wren, S., Kepl, E., Sydeman, C., King, N. P., Baldwin, S. L., Coler, R. N.
10.1101/2021.07.02.450915 — Posted: 2021-07-02
Ventilation and detection of airborne SARS-CoV-2: elucidating high-risk spaces in naturally ventilated healthcare settings
Styczynski, A., Hemlock, C., Hoque, K. I., Verma, R., LeBoa, C., Bhuiyan, M. O. F., Nag, A., Harun, M. G. D., Amin, M. B., Andrews, J. R.
10.1101/2021.06.30.21258984 — Posted: 2021-07-02
Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E
Zhu, Y., Scholle, F., Kisthardt, S. C., Xie, D.
10.1101/2021.07.01.450756 — Posted: 2021-07-02
Implications of Spike-glycoprotein processing at S1/S2 by Furin, at S2' by Furin and/or TMPRSS2 and shedding of ACE2: cell-to-cell fusion, cell entry and infectivity of SARS-CoV-2
Essalmani, R., Jain, J., Susan-Resiga, D., Andreo, U., Evagelidis, A., Derbali, M., Huynh, D., Dallaire, F., Laporte, M., Delpal, A., Sutto-Ortiz, P., Coutard, B., Mapa, C., Wilcoxen, K., Decroly, E., Pham, T. N., Cohen, E. A., Seidah, N. G.
10.1101/2021.07.02.450896 — Posted: 2021-07-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).